[摘要]目的：观察枸橼酸咖啡因对早产儿呼吸暂停的影响。方法：将2017

[Abstract] Objective: To observe the effect of caffeine citrate on apnea in premature infants. Methods: 84 cases of premature apnea infants hospitalized in our hospital from November 2017 to February 2020 were randomly divided into a test group and a control group, each with 42 cases. Both groups received continuous nasal airway ventilation treatment. Additional aminophylline treatment was added, and citrate caffeine treatment was added to the experimental group; early lung function parameters (ventilation per minute, tidal volume, peak time ratio, peak volume ratio) and clinical efficacy were compared between the two groups. Results: The above-mentioned early lung function parameters and clinical efficacy of the test group were significantly higher than those of the control group (both P <0.05). Conclusion: Caffeine citrate has significant effects on improving lung function and clinical symptoms in children with AOP, and has clinical application and promotion value.

Purpose: To observe the effect sephofation of pyriradum caffeine on apnea in premature infants. Methods: 84 cases of apafield preterm infants hospitalized in hospital from November 2017 to February 2020 were randomized into trial group and control group, each 42 cases, both groups received continuous airway ventilation treatment by nasal, the control group was treated with ammonia tea-alkali treatment, the test group added acid caffeine treatment; Results: The early lung function parameters and clinical efficacy were significantly higher than those in the control group (both P 0.05) in the experimental group. Conclusion: Caffeine has significant effect on lung function and clinical symptoms in AOP children, and has clinical application value.

[Abstract] Objective: To observe the effect of caffeine citrate on apnea in premature infants. Methods: from November 2017 to February 2020, 84 premature infants with apnea in our hospital were randomly divided into two groups: the experimental group and the control group, 42 cases in each group. Both groups were treated with nasal continuous airway ventilation, the control group was treated with aminophylline, and the experimental group was treated with caffeine citrate; compared with the early lung function parameters (ventilation per minute, tidal volume, peak time ratio, peak volume) of the two groups And clinical efficacy. Results: the early lung function parameters and clinical effect in the experimental group were significantly higher than those in the control group (P < 0.05). Conclusion: caffeine citrate can improve the lung function and clinical symptoms of AOP children significantly, and it has clinical application value.